SynthesisBioscience reports2020

Efficacy and safety of PARP inhibitors as the maintenance therapy in ovarian cancer: a meta-analysis of nine randomized controlled trials.

Fengping Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.